Skip to main content
letter
. 2018 Jun 4;16:78. doi: 10.1186/s12916-018-1073-z

Table 1.

Geospatial maps of the prevalence and incidence of resistance of selected bacteria-antibacterial drug combinations will be created

Bacteria Antibacterial drug(s)
Escherichia coli Third-generation cephalosporins, fluoroquinolones
Shigella species Fluoroquinolones
Klebsiella pneumoniae Third-generation cephalosporins, carbapenems
Streptococcus pneumoniae Penicillin
Staphylococcus aureus Methicillin
Salmonella Typhi and Paratyphi Fluoroquinolones, chloramphenicol
Non-typhoidal Salmonellae Fluoroquinolones
Neisseria gonorrhoeae Third-generation cephalosporins
Mycobacterium tuberculosis First-line – isoniazid, rifampicin
Second-line – fluoroquinolones, amikacin, capreomycin, kanamycin